Zacks Research has downgraded its Q3 2025 earnings estimate for Alexandria Real Estate Equities from $2.31 to $2.30 per share, reflecting a slight decrease in expectations. Recent earnings results showed Alexandria reported $2.33 EPS for the last quarter, which was above the consensus estimate of $2.29, but revenue fell short of expectations at $737.28 million. Several brokerages have significantly reduced price targets for Alexandria Real Estate Equities, with Citigroup lowering its target from $110 to $74. Mizuho dropped their price target from $121 to $91, Royal Bank of Canada from $100 to $98, Wedbush from $104 to $76, and JPMorgan Chase & Co. from $117 to $95. Ten analysts have rated the stock with a hold rating and two have assigned a buy rating, giving it a consensus rating of 'Hold' and an average price target of $97.17. Alexandria Real Estate Equities (ARE) last announced its quarterly earnings on July 21, reporting $2.33 EPS, beating the consensus estimate of $2.29 by $0.04. Revenue was $737.28 million, below the expected $748.02 million. The company had a negative net margin of 0.33% and a negative return on equity of 0.05%, with revenue down 0.6% year-over-year. The firm's revenue for the quarter was down 0.6% compared to the same quarter last year, and it posted $2.36 EPS in the same quarter of the prior year. The stock opened at $71.91 on Tuesday and has a market capitalization of $12.44 billion, a P/E ratio of -553.14, a PEG ratio of 6.25, and a beta of 1.24. The company has a quick ratio of 0.23, a current ratio of 0.23, and a debt-to-equity ratio of 0.61. The fifty-day simple moving average is $75.47 and the two-hundred-day simple moving average is $82.48. The twelve-month low is $67.37 and the twelve-month high is $125.63. The firm also declared a quarterly dividend paid on July 15, with investors of record on June 30 receiving a $1.32 dividend, representing a $5.28 annualized dividend and a dividend yield of 7.3%. The dividend payout ratio is currently -4,061.54%. Institutional investors have increased their holdings: Bank of America Corp DE increased its stake by 218.1%, Private Trust Co. NA by 19.2%, ProShare Advisors LLC by 53.8%, American Assets Investment Management LLC bought a new position worth about $569,000, and Cetera Investment Advisers by 35.0%. Approximately 96.54% of the stock is owned by institutional investors. Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since its founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and the Research Triangle.

Zacks Research Issues Negative Forecast for ARE Earnings

Zacks Research has downgraded its Q3 2025 earnings estimate for Alexandria Real Estate Equities (ARE) from $2.31 to $2.30 per share. Alexandria reported $2.33 EPS, exceeding the consensus estimate of $2.29, but revenue fell short at $737.28 million versus the expected $748.02 million. The company posted a negative net margin of 0.33% and a negative return on equity of 0.05%, with revenue down 0.6% year-over-year. Several major brokerages have reduced their price targets, including Citigroup, Mizuho, Royal Bank of Canada, Wedbush, and JPMorgan Chase & Co. The stock has a market capitalization of $12.44 billion, a negative P/E ratio of -553.14, and a dividend yield of 7.3%. Institutional investors have increased their holdings, with Bank of America Corp DE, Private Trust Co. NA, ProShare Advisors LLC, American Assets Investment Management LLC, and Cetera Investment Advisers among those who boosted their positions. The company, a life science REIT, operates in key innovation clusters such as Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and the Research Triangle.